TAP
57
6
JNJ
30
4
CI
35
2
SLG
37
6
FITB
36
3
NTAP
58
3
EOG
28
2
HPE
48
2
KMI
69
8
NVDA
52
5
HD
43
8
KR
50
5
EXR
42
5
CMCSA
49
3
CA
19
6
CMI
49
2
SYK
50
4
IPG
43
3
INTU
54
2
ADBE
50
3
TAP
57
6
JNJ
30
4
CI
35
2
SLG
37
6
FITB
36
3
NTAP
58
3
EOG
28
2
HPE
48
2
KMI
69
8
NVDA
52
5
HD
43
8
KR
50
5
EXR
42
5
CMCSA
49
3
CA
19
6
CMI
49
2
SYK
50
4
IPG
43
3
INTU
54
2
ADBE
50
3
Financhill
Back

Palisade Bio Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
27

PALI
Palisade Bio

Last Price:
$1.76
Seasonality Move:
3.19%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
$0.53
Seasonality Move:
-0.66%
Sell
27
Palisade Bio (PALI) is a Sell

Is Palisade Bio a Buy, Sell or Hold?

  • The current Palisade Bio [PALI] share price is $1.75. The Score for PALI is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PALI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PALI Stock Price Chart

What is Palisade Bio's stock price today?

  • The Palisade Bio share price today is $1.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PALI is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PALI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 41.27 Sell
Chaikin Money Flow: -119507 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.75 - 2.45) Sell
Bollinger Bands (100): (2.4 - 3.8) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.44 Sell
Chaikin Money Flow: 514099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.67) Sell
Bollinger Bands (100): (0.49 - 0.69) Sell

PALI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.83 Sell
20-day SMA: 2.01 Sell
50-day SMA: 2.61 Sell
200-day SMA: 4.17 Sell
8-day EMA: 1.82 Sell
20-day EMA: 2.01 Sell
50-day EMA: 2.48 Sell
200-day EMA: 7.47 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.54 Sell
20-day SMA: 0.57 Sell
50-day SMA: 0.63 Sell
200-day SMA: 1.88 Sell
8-day EMA: 0.54 Sell
20-day EMA: 0.57 Sell
50-day EMA: 0.64 Sell
200-day EMA: 4.7 Sell

Palisade Bio Earnings Growth & PALI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.15 per share, and an increase next year of $8.16 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Palisade Bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):